Oncology for children: what can be done when resources are scarce?

Relapsed Hodgkin lymphoma in PET positive patients

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer

Integrating multiple omics information in the era of precision oncology

'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer

The role of the microenvironment and novel therapies in CLL

p62: Metabolism and the tumour microenvironment

Cancer cells plasticity and drug resistance

Drugging “undruggable” transcription factor drivers in cancer

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer

Elucidation and pharmacological targeting of tumour checkpoint dependencies